Green Cross Medical Science Corporation Cash Flow Quality Index
Green Cross Medical Science Corporation cash flow quality index. Green Cross Medical Science Corporation (142280) has a Cash Flow Quality Index of -1.11x as of March 2026. Operating cash flow of ₩-160.64 Million is below net income of ₩144.53 Million, suggesting accrual-heavy earnings not yet converted to cash. See Green Cross Medical Science Corporation (142280) financial flexibility to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Green Cross Medical Science Corporation (2014–2025)
Cash flow quality index of Green Cross Medical Science Corporation from 2014 to 2025. Historical Cash Flow Quality Index for Green Cross Medical Science Corporation across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore 142280 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Green Cross Medical Science Corporation Cash Flow Quality Index by Year (2014–2025)
Green Cross Medical Science Corporation cash flow quality index by year from 2014 to 2025. Year-by-year earnings quality comparison for Green Cross Medical Science Corporation. For the full cash flow conversion analysis, see Green Cross Medical Science Corporation (142280) cash flow conversion.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.96x | ₩7.20 Billion | ₩3.67 Billion | ▲ +82.1% |
| 2024 | 1.08x | ₩3.66 Billion | ₩3.40 Billion | ▼ -52.3% |
| 2023 | 2.26x | ₩4.24 Billion | ₩1.88 Billion | ▲ +273.3% |
| 2020 | -1.30x | ₩-8.76 Billion | ₩6.72 Billion | ▲ +85.6% |
| 2015 | -9.03x | ₩-5.45 Billion | ₩603.26 Million | ▼ -1412.9% |
| 2014 | -0.60x | ₩-2.22 Billion | ₩3.72 Billion | — |